Skip to content
Recall Observatory FDA recall evidence

Drug product

PAPAVERINE-PHENTOLAMINE-PGE1 23-0.96MG-19.2MCG/ML INJECTABLE, (a) 5ml, (b) 6.5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

D-1096-2019

February 21, 2019

Class II

Product summary

Firm
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy
Event
Event 82278
Status
Terminated
Classification
Class II
Quantity
2 prescription 5, 6.5 ml injection
Official record key
drug-enforcement:D-1096-2019

Official wording

Reason: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

Code information: Lot: (a) 22102018@31, (b) 09112018@33, distributed between 09-01-2018 to 02-20-2019.

Distribution pattern: Dispensed in Oregon

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    Lack of Processing Controls